Key Highlights
- The NOHO ticker has long been associated with Novation Holdings Inc, a small diversified Holding Company with ventures spanning internet access to music-industry collaborations.
- Data providers now show the ticker associated with a renamed entity, Dragon Life Science Holdings Group, Inc.
- No verified, market-moving announcement, such as a completed acquisition, financing, or new operating business, has been independently confirmed.
- The company's market Capitalization is only in the tens of thousands of dollars, consistent with a micro-shell structure.
NOHO (OTC:NOHO) is a reminder of how tangled the identity of a deep-penny OTC ticker can become. The symbol has long been associated with Novation Holdings Inc, but market-data providers now list the entity under a different corporate name, reflecting the kind of rebranding common among tiny, shell-like companies.
Company and Latest Development
Novation Holdings Inc has functioned as a small, diversified holding company, and its history spans several unrelated ventures, from internet-access and educational services to a music-industry collaboration announced years ago. More recently, data providers show the ticker associated with a renamed entity, Dragon Life Science Holdings Group, Inc., indicating a change in corporate identity or direction.
No verified, market-moving announcement, such as a completed acquisition, financing or new operating business, has been independently confirmed as a current catalyst, and the most recent widely visible news items date back several years.
What Is Driving Attention Around NOHO?
There is no single, verifiable public catalyst behind recent interest. At a quote of roughly one-millionth of a dollar, NOHO exhibits the classic profile of a dormant or shell-stage OTC security: negligible daily movement, extremely thin trading and a high Beta that reflects how a handful of shares can swing the quote.
Screeners and speculative traders are drawn to such names precisely because they are cheap and volatile, not because of confirmed developments.
Key Numbers and Company Position
Hard figures are scarce and should be treated cautiously. The company's market capitalization is only in the tens of thousands of dollars, consistent with a micro-shell structure. Reported employee counts are minimal, and there is no analyst coverage or rating.
Because disclosure has been limited and the corporate identity appears to have shifted, investors cannot rely on a steady stream of audited financials the way they might with a larger listed company.
What Could Come Next?
For a name like NOHO, the plausible catalysts are structural: a Reverse merger that injects an operating business, a new financing, a change of control tied to the apparent rebranding, or a resumption of regular SEC or OTC disclosure.
Any confirmation of what Dragon Life Science Holdings Group intends to pursue, genuine operating plans, Assets or partnerships, would be the key development to monitor.
Risks to Watch
The risks here are among the highest in public markets. Shell-stage, sub-penny OTC tickers carry extreme volatility, near-total illiquidity and a real possibility of complete loss. Corporate name changes and shifting Business focus can precede reverse mergers that heavily dilute existing holders.
Limited, dated disclosure makes independent verification difficult, and the absence of current, audited financials is itself a material risk.
A Ticker in Search of a Settled Identity
NOHO sits at the speculative fringe of the OTC market: a ticker historically tied to Novation Holdings Inc, now associated with a renamed entity, trading at a fraction of a cent with no confirmed catalyst. The next meaningful move would most likely stem from a structural event, a reverse merger, financing or fresh operating strategy under the new name.
Investors watching NOHO may want to track OTC and SEC disclosures closely and weigh the significant risk of total loss.





_11_19_2026_08_23_11_186799.jpg)
Please wait processing your request...